Company intelligence / Profile preview

Anymedi

South Korea

Ownership: Private
Development stage: Other

Overview

Anymedi has commercialized AI- and 3D-printing–based, patient-specific surgical planning and guide solutions (including VR/AR tools and printed simulators, guides, and implants) that have been applied in 100+ published clinical cases and over 400 customized guide surgeries, supporting improved precision and outcomes in multiple surgical fields[1][2][5][7].

Therapeutic areas: OncologyRare DiseasesOther
Modalities: DeviceNon-pharmacological therapy
Industry: Surgical Medical Devices

Partnerships

Lima Korea (Lima Corporate) – collaboration to introduce and expand personalized surgical guides for shoulder artificial joint replacement in Korea, covering technology, sales, and marketing cooperation[2].

Beyond the preview

Go deeper on Anymedi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anymedi.

Explore the full profile